BRAF and melanoma: Presence of unusual variants of BRAF mutations seen in 3 of our cases might be more in favor of metastatic NSCLC than melanoma, given the vanishing rarity of these variant mutations in dedifferentiated melanoma and, instead, the predominance of the classical V600E mutation in melanoma [5, 6, 23].